Geode Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,831,951 shares of ITCI stock, worth $242 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,831,951
Previous 1,716,829
6.71%
Holding current value
$242 Million
Previous $143 Million
68.54%
% of portfolio
0.02%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
68.1MCall Options Held
934KPut Options Held
758K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.49MShares$460 Million16.46% of portfolio
-
Ubs Oconnor LLC Chicago, IL3.09MShares$408 Million28.36% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.06MShares$403 Million2.32% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...